Disease: Long QT syndrome type 3
- <em>ARumenamides</em>: A novel class of potential antiarrhythmic compounds
- A case report of a young patient with both Brugada and long QT3 syndrome: between the hammer and the anvil
- A Novel Frameshift Mutation, <em>KCNH2</em> [p.Asp896ArgfsX79], Leading to Malignant Ventricular Arrhythmia, Identified After Treatment of Gastrointestinal Bleeding
- A phenotype-enhanced variant classification framework to decrease the burden of missense variants of uncertain significance in type 1 long QT syndrome
- A Possible Explanation for the Low Penetrance of Pathogenic KCNE1 Variants in Long QT Syndrome Type 5
- An electrophysiological substrate of COVID-19
- Analysis of the shape of the T-wave in congenital long-QT syndrome type 3 by geometric morphometrics
- Assessment of QT Interval Abnormalities on Electrocardiogram in Children With Breath-Holding Spells
- Association Between Syncope Trigger Type and Risk of Subsequent Life-Threatening Events in Patients With Long QT Syndrome
- Beckwith-Wiedemann syndrome with long QT caused by a deletion involving KCNQ1 but not KCNQ1OT1:TSS-DMR
- Beneficial effects of chronic mexiletine treatment in a human model of SCN5A overlap syndrome
- Binding characteristics of calpastatin domain L to Na<sub>V</sub>1.5 sodium channel and its IQ motif mutants
- Calmodulin Mutations in Human Disease
- Cardiac crises: Cardiac arrhythmias and cardiomyopathy during TANGO2 deficiency related metabolic crises
- Catheter ablation of frequent monomorphic ventricular arrhythmias in Andersen-Tawil syndrome: case report and focused literature review
- Caveolin-3 and Arrhythmias: Insights into the Molecular Mechanisms
- Celebrities in the heart, strangers in the pancreatic beta cell: Voltage-gated potassium channels K<sub>v</sub> 7.1 and K<sub>v</sub> 11.1 bridge long QT syndrome with hyperinsulinaemia as well as type 2 diabetes
- Characteristics of Cardiac Abnormalities in Pediatric Patients With Acute COVID-19
- Clinical Spectrum of <em>SCN5A</em> Channelopathy in Children with Primary Electrical Disease and Structurally Normal Hearts
- Combined mexiletine and flecainide for severe long QT syndrome type 3
- Common Ancestry-Specific Ion Channel Variants Predispose to Drug-Induced Arrhythmias
- Computational Study on Effect of KCNQ1 P535T Mutation in a Cardiac Ventricular Tissue
- COVID-19 vaccination in patients with long QT syndrome
- Deep learning analysis of electrocardiogram for risk prediction of drug-induced arrhythmias and diagnosis of long QT syndrome
- Detection of distant familial relatedness in biobanks for identification of undiagnosed carriers of a Mendelian disease variant: application to Long QT syndrome
- Diagnostic lacunae and implications of an automated implantable cardioverter defibrillator implantation in a child with type 3 Long QT (LQT3) syndrome
- Docosahexaenoic acid normalizes QT interval in long QT type 2 transgenic rabbit models in a genotype-specific fashion
- Editorial: Case Reports in Pediatric Cardiology: 2021
- Effect of hyperglycaemia in combination with moxifloxacin on cardiac repolarization in male and female patients with type I diabetes
- Electroacupuncture Ameliorates Acute Myocardial Ischemic Injury and Long QT Interval in Mice through the <em>α</em> <sub>1A</sub>-Adrenergic Receptor: Electrophysiological, Morphological, and Molecular Evidence
- Evaluation of Teneligliptin a DPP4 Inhibitor in Terms of Efficacy and Safety with Respect to QT/QTc Prolongation in Patients with Type II Diabetes Mellitus (T2DM)
- Excellent response to β-1 adrenergic receptor blockade (metoprolol) and exercise restriction in high-risk type 1 long QT syndrome. A 22-year follow-up
- Functional characterization and identification of a therapeutic for a novel SCN5A-F1760C variant causing type 3 long QT syndrome refractory to all guideline-directed therapies
- Functional hyperactivity in long QT syndrome type 1 pluripotent stem cell-derived sympathetic neurons
- Gene- and variant-specific efficacy of serum/glucocorticoid-regulated kinase 1 inhibition in long QT syndrome types 1 and 2
- Generation and characterization of the human induced pluripotent stem cell (hiPSC) line NCUFi001-A from a patient carrying KCNQ1 G314S mutation
- Heart rate-corrected QT interval prolongation is associated with decreased heart rate variability in patients with type 2 diabetes
- Hypernatremia and intercalated disc edema synergistically exacerbate long-QT syndrome type 3 phenotype
- I<sub>Ks</sub> Activator ML277 Mildly Affects Repolarization and Arrhythmic Outcome in the CAVB Dog Model
- I<sub>Ks</sub> inhibitor JNJ303 prolongs the QT interval and perpetuates arrhythmia when combined with enhanced inotropy in the CAVB dog
- Improving Corrected QT Interval Monitoring in Critical Care Units: A Single Center Report
- In Vivo Base Editing of <em>Scn5a</em> Rescues Type 3 Long QT Syndrome in Mice
- In Vivo Base Editing of Scn5a Rescues Type 3 Long QT Syndrome in Mice
- Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk)
- Inducible over-expression of cardiac Nos1ap causes short QT syndrome in transgenic mice
- Initiation of ventricular arrhythmia in the acquired long QT syndrome
- Injectable contraceptive Depo-Provera induces erratic beating patterns in patient-specific induced pluripotent stem cell-derived cardiomyocytes with long QT syndrome type 2
- Intravenous lidocaine in malignant long QT type 3: A bridge over troubled waters
- L-Type Calcium Channel: Predicting Pathogenic/Likely Pathogenic Status for Variants of Uncertain Clinical Significance
- Mexiletine
- Mexiletine
- Mexiletine in a Newborn with Type 3 Long QT Syndrome: When Access is Difficult
- Mexiletine Treatment for Neonatal LQT3 Syndrome: Case Report and Literature Review
- Modeling incomplete penetrance in long QT syndrome type 3 through ion channel heterogeneity: an in silico population study
- Multifocal ectopic purkinje-related premature contractions and related cardiomyopathy
- Mutational spectrum of congenital long QT syndrome in Turkey; identification of 12 novel mutations across KCNQ1, KCNH2, SCN5A, KCNJ2, CACNA1C, and CALM1
- Na<sub>V</sub>1.5 knockout in iPSCs: a novel approach to study Na<sub>V</sub>1.5 variants in a human cardiomyocyte environment
- Novel <em>CALM3</em> Variant Causing Calmodulinopathy With Variable Expressivity in a 4-Generation Family
- Novel CACNA1C R511Q mutation, located in domain Ⅰ-Ⅱ linker, causes non-syndromic type-8 long QT syndrome
- Novel Calmodulin Variant p.E46K Associated With Severe Catecholaminergic Polymorphic Ventricular Tachycardia Produces Robust Arrhythmogenicity in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
- Novel trans-2,3-enoyl-CoA reductase-like variant associated with catecholaminergic polymorphic ventricular tachycardia type 3
- Peripartum management of patient with long QT3 after successful implantable cardioverter defibrillator device discharge resulting in device failure: a case report
- Phenotypic Characterization of Timothy Syndrome Caused by the <em>CACNA1C</em> p.Gly402Ser Variant
- Polypharmacy-Induced Long QT Syndrome in a Patient With Newly Diagnosed Acute Myeloid Leukaemia: A Case Report
- Prediction of arrhythmia susceptibility through mathematical modeling and machine learning
- Prolongation of the heart rate-corrected QT interval is associated with cardiovascular diseases: Systematic review and meta-analysis
- Proof of concept for monoclonal antibody therapy in a cellular model of acquired long QT syndrome type 3
- Proof-of-concept for monoclonal antibody therapy in a cellular model of acquired long QT syndrome type 3
- Publisher Correction: Analysis of the shape of the T-wave in congenital long-QT syndrome type 3 by geometric morphometrics
- QTc prolongation Safety and Effectiveness of Teneligliptin in Indian patients with type 2 Diabetes Mellitus: A real world study (QSET 2)
- Recurrent Pregnancy Loss and Concealed Long-QT Syndrome
- Relationship of electrocardiographic changes and severity of acute cerebral ischemic stroke in old patients: A clinical observational study
- Renal artery denervation prevents ventricular arrhythmias in long QT rabbit models
- Reprogramming of a human induced pluripotent stem cell line (ZZUSAHi004-A) from a long QT syndrome patient with a heterozygous AKAP9 (c. 4021C > A) mutant
- Reprogramming of a human induced pluripotent stem cell line from a long QT syndrome patient harboring a heterozygous mutation of c.1537C > T in SCN5A gene
- Resuscitated Sudden Cardiac Arrest of a Neonate with Congenital LQT Syndrome-Associated Torsades de Pointes: A Case Report and Literature Review
- Risk of Arrhythmia Among New Users of Hydroxychloroquine in Rheumatoid Arthritis and Systemic Lupus Erythematosus: A Population-Based Study
- Risk Prediction in Women With Congenital Long QT Syndrome
- Role and mechanism of chaperones calreticulin and ERP57 in restoring trafficking to mutant HERG‑A561V protein
- Role of chronic continuous intravenous lidocaine in the clinical management of patients with malignant type 3 long QT syndrome
- Same Gene, Different Story (a Case Report of Congenital Long QT Syndrome Subtype 8 With a Novel Mutation)
- SCN5A-1795insD founder variant: a unique Dutch experience spanning 7 decades
- Severe Hypoglycemia and Incidence of QT Interval Prolongation Among Adults With Type 2 Diabetes
- Sex hormones and repolarization dynamics during the menstrual cycle in women with congenital long QT syndrome
- Spectrum and prevalence of side effects and complications with guideline-directed therapies for congenital long QT syndrome
- Successful Subcutaneous Defibrillator Implantation in a Pregnant Patient With Long QT Syndrome
- Successful vaginal delivery in a parturient with long QT syndrome type 2 using double-catheter epidural analgesia: A CARE-compliant case report
- Sustained heart rate-corrected QT prolongation during recovery from hypoglycaemia in people with type 1 diabetes, independently of recovery to hyperglycaemia or euglycaemia
- The Antiarrhythmic Action of the Na<sup>+</sup>/Ca<sup>2+</sup> Exchanger Inhibitor SEA0400 on Drug-Induced Long QT Syndrome Depends on the Severity of Proarrhythmic Conditions in Anesthetized Atrioventricular Block Rabbits
- The long-term efficacy of left cardiac sympathetic denervation in long QT syndrome
- The Outcome of Long QT Syndrome, a Korean Single Center Study
- Time Course and Risk Factors of New-Onset Complete Atrioventricular Block After Transcatheter Aortic Valve Implantation
- To Modify or Not to Modify: Allele-Specific Effects of 3'UTR-<em>KCNQ1</em> Single Nucleotide Polymorphisms on Clinical Phenotype in a Long QT 1 Founder Population Segregating a Dominant-Negative Mutation
- Torsade de Pointes secondary to long QT syndrome after intragastric balloon placement. A rare but severe complication
- Triggers, characteristics, and hospital outcome of patients with Takotsubo syndrome: 10 years experience in a large university hospital centre
- Use of subcutaneous cardioverter-defibrillator. First cases reported from National Institute of Cardiology Ignacio Chávez-Mexico
- Using Ribonucleoprotein-based CRISPR/Cas9 to Edit Single Nucleotide on Human Induced Pluripotent Stem Cells to Model Type 3 Long QT Syndrome (SCN5A<sup>±</sup>)
- Variant-specific therapy for long QT syndrome type 3
- When the Gates Swing Open Only: Arrhythmia Mutations That Target the Fast Inactivation Gate of Na<sub>v</sub>1.5
- Whole-exome sequencing and electrophysiological study reveal a novel loss-of-function mutation of KCNA10 in epinephrine provoked long QT syndrome with familial history of sudden cardiac death